Trond Engjom

Trond Engjom

Auto-generated profile, based on publicly available information

Trond Engjom

Department of Clinical Medicine, University of Bergen, Bergen, Norway; Department of Medicine, Haukeland University Hospital, Bergen, Norway

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in Pancreas
Verified
Journal Article
Open access
FEFriedemann Erchinger
Friedemann Erchinger
TETrond Engjom
Trond Engjom
ETErling Tjora
Erling Tjora
DHDag Hoem
Dag Hoem
THTrygve Hausken
Trygve Hausken
GDGeorg Dimcevski
Georg Dimcevski
Background: Monogenic diabetes (Maturity onset diabetes in the young, MODY) are autosomal dominantly inherited diabetes syndromes characterized by diabetes due to beta cell dysfunction, with typical onset of diabetes before 25 years of age. Two MODY subtypes, HNF1B-MODY and CEL-MODY, have been associated with exocrine pancreatic dysfunction. Assessment of exocrine pancreatic function is a challenge due to few available tests with acceptable feasibility and diagnostic value.Aims: In the present study we wanted to evaluate two novel methods for measuring pancreatic exocrine function; a rapid endoscopic secretin test and a dynamic magnetic resonance imaging (MRI) based protocol. We further wanted to use these two methods to assess the degree and nature of exocrine pancreatic dysfunction in CELMODY and HNF1B-MODY.Materials and methods: We recruited 52 consecutive patients with suspected chronic pancreatitis, 23 patients with CEL-MODY and 8 patients with HNF1B-MODY. Suspected chronic pancreatitis patients underwent the endoscopic procedure only, while MODY patients were offered endoscopy and MRI procedure. In addition, 25 healthy controls underwent endoscopy and 20 healthy controls underwent the MRI protocol. In patients with suspected chronic pancreatitis, a renowned multimodal clinical score was used as reference standard. In MODY patients results from the examinations were compared to nutritional status as achieved from patient records before any treatment with pancreatic enzyme supplements. The endoscopic procedure started 30 minutes after secretin stimulation, with 15 minutes collection of duodenal juice. Duodenal juice was analyzed for bicarbonate in chronic pancreatitis patients, and for bicarbonate and digestive enzyme activities in MODY-patients and healthy controls. The MRI protocol consisted of anatomical imaging, followed by dynamic imaging before and after secretin stimulation. The dynamic series consisted of repeated duodenal fluid volume quantification with magnetic resonance cholangiopancreaticography (MRCP) and measuring apparent diffusion coefficient (ADC) in pancreatic tissue using diffusion-weighted imaging.Results: Using bicarbonate as diagnostic marker, the rapid endoscopic secretin test had acceptable diagnostic value in detecting chronic pancreatitis, and performed significantly better than fecal elastase 1. In healthy controls, increase in secretin stimulated duodenal fluid volumes correlated well with changes in ADC after secretin stimulation. In CEL-MODY patients we found moderately low bicarbonate levels and reduced pancreatic fluid output, and severely reduced digestive enzyme activity levels compared to controls. With exception from low levels of vitamin E, CEL-MODY patients revealed no signs of malnutrition. In HNF1B-MODY patients we found moderately reduced bicarbonate levels, reduced pancreatic fluid output and moderately reduced levels of digestive enzyme activities compared to controls. Pancreatic gland volumes were small in all but one HNF1B-MODY patients, but pancreatic volume output per gland size was increased.Conclusions: Both rapid endoscopic secretin test and the MRI protocol are feasible and well tolerated examination modalities reflecting pancreatic exocrine function. CEL-MODY patients have moderately reduced ductal and severely reduced acinar pancreatic function, but compensated nutritional status. HNF1B-MODY patients have moderately reduced ductal and acinar pancreatic function, partly compensated by hypersecretion from a hypoplastic pancreas.

16 February 2022 in Pancreatology
Verified
Journal Article
Open access
FEFriedemann Erchinger
Friedemann Erchinger
TETrond Engjom
Trond Engjom
GDGeorg Dimcevski
Georg Dimcevski
ADAsbjørn M. Drewes
Asbjørn M. Drewes
SOSøren Schou Olesen
Søren Schou Olesen
ETErling Tjora
Erling Tjora
There is scarce information about risk factors for exocrine pancreas insufficiency (EPI) in chronic pancreatitis (CP), and how it associates with other complications. The aim of the present study was to examine risk factors for EPI and associations to procedures and other CP related complications in a large, Northern European cohort. We retrieved cross-sectional data on demographics, status on EPI, aetiological risk factors for CP, CP related complications as well as surgical and endoscopic treatment from the Scandinavian Baltic Pancreatic Club Database. Associations were assessed by univariate and multivariate logistic regression analyses. Results are presented as odds ratios (OR) with 95% confidence intervals. We included 1869 patients with probable or definitive CP in the study. Exocrine pancreas insufficiency was present in 849 (45.4%) of patients. In multivariate analyses, EPI associated with smoking aetiology (OR 1.47 (1.20-1.79), p < 0.001), and nutritional/metabolic aetiology (OR 0.52 (0.31-0.87), p = 0.01) to CP. Pancreatic or common bile duct stenting procedure and pancreatic resection were both associated with EPI (ORs 1.44 (1.15-1.80), p = 0.002 and 1.54 (1.02-2.33), p = 0.04, respectively). The presence of diabetes mellitus (OR 2.45 (1.92-3.15), p < 0.001), bile duct stenosis (OR 1.48 (1.09-2.00), p = 0.02) and underweight (2.05 (OR 1.40-3.02), p < 0.001) were all associated with presence of EPI. Smoking, bile duct stenosis, previous stenting and resection procedures are all associated with EPI in patients with CP. Presence of EPI were also associated with malnutrition and diabetes mellitus. Hence, intensive nutritional surveillance is needed in these patients.

1 April 2017 in Ultrasound in Medicine & Biology
Verified
Journal Article
Open access
TETrond Engjom
Trond Engjom
DSDag A. Sangnes
Dag A. Sangnes
RHRoald F. Havre
Roald F. Havre
FEFriedemann Erchinger
Friedemann Erchinger
KPKhanh Do Cong Pham
Khanh Do Cong Pham
GDGeorg Dimcevski
Georg Dimcevski
The performance of transabdominal ultrasound (US) in chronic pancreatitis (CP) following the advances in US technology made during recent decades has not been explored. Our aim in this prospective study was to evaluate the diagnostic accuracy of modern abdominal US compared with the Mayo score in CP. One hundred thirty-four patients referred for suspected CP were included in the study. Fifty-four patients were assigned the diagnosis CP. After inclusion, transabdominal US was performed. Ductal features (calculi, dilations and caliber variations, side-branch dilations and hyper-echoic duct wall margins) and parenchymal features (calcifications, cysts, hyper-echoic foci, stranding, lobulation and honeycombing) were recorded. Features were counted and scored according to a weighting system defined at the international consensus meeting in Rosemont, Illinois (Rosemont score). Diagnostic performance indices (95% confidence interval) of US were calculated: The unweighted count of features had a sensitivity of 0.69 (0.54-0.80) and specificity of 0.97 (0.90-1). The Rosemont score had a sensitivity of 0.81 (0.69-0.91) and specificity of 0.97 (0.90-1). Exocrine pancreatic failure was most pronounced in Rosemont groups I and II (p < 0.001). We conclude that using both unweighted and weighted scores, the diagnostic accuracy of modern transabdominal US is good. The extent of pancreatic changes detected by the method is correlated with exocrine pancreatic function.

1 November 2015 in Pancreas
Verified
Journal Article
Open access
TETrond Engjom
Trond Engjom
FEFriedemann Erchinger
Friedemann Erchinger
BLBirger Norderud Lærum
Birger Norderud Lærum
ETErling Tjora
Erling Tjora
LALage Aksnes
Lage Aksnes
GDGeorg Dimcevski
Georg Dimcevski
Objective Short endoscopic secretin tests for exocrine pancreatic function are not properly evaluated in cystic fibrosis (CF). Methods Patients with CF and healthy controls (HCs) underwent endoscopic collection of duodenal juice between 30 and 45 minutes after secretin stimulation. Duodenal juice was analyzed for HCO3− concentration and pancreatic enzyme activities. Stool was analyzed for fecal elastase. Results Thirty-one patients with CF and 25 HCs were tested. Patients were classified as exocrine pancreatic sufficient (n = 13) or insufficient (n = 18). Both bicarbonate concentrations and enzyme activities in duodenal juice differentiated patients with CFI from patients with CFS and HC (P < 0.001). The population displays strong correlation between severe CF genotype in both alleles and pancreatic insufficient phenotype (P < 0.001). Conclusions Pancreatic exocrine insufficient CF patients could be differentiated from exocrine sufficient patients and HCs using short endoscopic secretin test.

22 January 2016 in Endoscopy
Verified
Journal Article
Closed access
PDF file
KPKhanh Do Cong Pham
Khanh Do Cong Pham
TETrond Engjom
Trond Engjom
HKHilde Gjelberg Kollesete
Hilde Gjelberg Kollesete
LHLars Helgeland
Lars Helgeland
Pancreatic cystic lesions (PCLs) are detected in over 2 % of patients who undergo computed tomography (CT) and magnetic resonance imaging screening [1] [2]. Most PCLs are harmless, but some have the potential for malignant transformation. The management of PCLs is challenging, with high resource use. The standard option for the acquisition of cellular material from PCLs is endoscopic ultrasound (EUS)-guided fine-needle aspiration (FNA). Although many types of needles are available [3], it is usually not possible to obtain a reliable biopsy from the cyst wall for a more certain histological diagnosis. In four recently reported cases, a through-the-needle forceps was used to obtain biopsies from PCLs [4] [5] [6]. We report the first case in which a novel through-the-needle micro forceps (Moray, US Endoscopy, Ohio, USA) ([Fig. 1]) was used to diagnose a PCL, and to biopsy and resect an intracystic nodule. The patient was an 85-year-old woman with an incidental finding of a 30 × 20 mm solitary PCL in the body of the pancreas on CT scan. The finding was also apparent on EUS. The lesion showed no connection with the pancreatic ducts, but a small nodule could be seen inside the cyst ([Fig. 2 a, b]). A 19-G FNA needle (EchoTip Ultra; Cook Medical, Limerick, Ireland) was used to access the cyst. After the stylet was removed, a micro forceps was advanced through the FNA needle into the cyst, and four biopsies were taken from the cyst wall. In addition, the cyst fluid, which was serous, was aspirated. The nodular lesion was biopsied and then resected ([Video 1]). The patient was observed for 2 hours after the procedure, and then discharged. No complications were reported at 2 weeks’ follow-up. The cyst fluid revealed few mucinous cells. Carcinoembryonic antigen and amylase levels were in the normal range. The biopsies showed mucinous epithelium consistent with a mucinous cyst, and a nodule made up of connective tissue with a mucinous lining ([Fig. 3]). Endoscopy_UCTN_Code_TTT_1AS_2AD

10 November 2016 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
AMAdnan Madzak
Adnan Madzak
TETrond Engjom
Trond Engjom
GWGaute K. Wathle
Gaute K. Wathle
SOSøren Schou Olesen
Søren Schou Olesen
ETErling Tjora
Erling Tjora
IHIngfrid Salvesen Haldorsen
Ingfrid Salvesen Haldorsen